Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Safety of Additional Injection of Autologous Platelet-rich Stroma to Surgical Treatment of Rectovaginal Fistulas

NCT06798935 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06798935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06798935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Safety of Additional Injection of Autologous Platelet-rich Stroma to Surgical Treatment of Rectovaginal Fistulas
Lead sponsor
Erasmus Medical Center
Phase
Phase 2
Overall status
Completed
Start date
January 11, 2019
Completion date
September 4, 2024
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anovaginal fistula, rectovaginal fistula